mycophenolate sodium
mycophenolate sodium is a pharmaceutical drug with 14 clinical trials. Currently 3 active trials ongoing. Historical success rate of 90.9%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
3
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
90.9%
10 of 11 finished
9.1%
1 ended early
3
trials recruiting
14
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function
Enteric-coated Mycophenolate Sodium (Myfortic®) in Heart Transplant Recipients
Clinical Trials (14)
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function
Enteric-coated Mycophenolate Sodium (Myfortic®) in Heart Transplant Recipients
Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients
Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS
Everolimus in de Novo Kidney Transplant Recipients
Conversion From Mycophenolate Mofetil to Mycophenolate Sodium in Renal Transplant
A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS)
Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate
The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis
Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare
Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome
All 14 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 14